Contact Molecules for Homologous Proteins
[Summary Bars]	[Full Bars]	Site Table[0 %]	[Back to Search Page]	[Back to HOMCOS]
[Sites by Variants]	[SupCon3D]	[help]	seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100]	[show] [download] [help]

PID	QueryLength	Homolgous Sequence in PDB	UniProt Query	TITLE
3207930	164	29	P01185(NEU2_HUMAN)	RecName: Full=Vasopressin-neurophysin 2-copeptin;AltName: Full=AVP-NPII;Contains: RecName: Full=Arg-vasopressin; AltName: Full=Arginine-vasopressin;Contains: RecName: Full=Neurophysin 2; AltName: Full=Neurophysin-II;Contains: RecName: Full=Copeptin;Flags: Precursor;
QUERYSEQ	MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENYLPSPCQSGQKACGSGGRCAAFGVCCNDESCVTEPECREGFHRRARASDRSNATQLDGPAGALLLRLVQLA GAPEPFEPAQPDAY

  [n]:site number of query sequence.  [a]:amino acid of query sequence.  [s]:predicted secondary structure.
  [e]:predicted exposed/buried.  [acc]:predicted relative accesssibility(%).  [pdb]:PDB code of homologous structure.
  [contact_mols]:predicted binding molecules  [observed aa]:Observed amino acids among homologous sequences.  [feature table]:UniProt Feature Table
  [variant]:UniProt Human Variant.

n	a	s	e	acc	pdb	contact_mols	observed aa	feature table	variant
1	M	-	-	-	-		M	SIGNAL DISORDER predicted by DISOPRED SIGNAL
2	P	-	-	-	-		PSTLA	SIGNAL DISORDER predicted by DISOPRED SIGNAL
3	D	-	-	-	-		DGLNYEH	SIGNAL DISORDER predicted by DISOPRED SIGNAL
4	T	-	-	-	-		TSAP	SIGNAL DISORDER predicted by DISOPRED SIGNAL
5	M	-	-	-	-		TAYVFSM	SIGNAL DISORDER predicted by DISOPRED SIGNAL
6	L	-	-	-	-		LIV	SIGNAL DISORDER predicted by DISOPRED SIGNAL
7	P	-	-	-	-		PLSA	SIGNAL DISORDER predicted by DISOPRED SIGNAL
8	A	-	-	-	-		LAVT	SIGNAL DISORDER predicted by DISOPRED SIGNAL
9	C	-	-	-	-		CATLS	SIGNAL DISORDER predicted by DISOPRED SIGNAL
10	F	-	-	-	-		FLVACI	SIGNAL DISORDER predicted by DISOPRED SIGNAL
11	L	-	-	-	-		LVAFI	SIGNAL DISORDER predicted by DISOPRED SIGNAL
12	G	-	-	-	-		GCLYFS	SIGNAL DISORDER predicted by DISOPRED SIGNAL
13	L	-	-	-	-		LISAWG	SIGNAL DISORDER predicted by DISOPRED SIGNAL
14	L	-	-	-	-		LS	SIGNAL DISORDER predicted by DISOPRED SIGNAL
15	A	-	-	-	-		ASCL	SIGNAL SIGNAL
16	F	-	-	-	-		LVFQA	SIGNAL SIGNAL
17	S	-	-	-	-		STCA	SIGNAL SIGNAL	S->F:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
18	S	-	-	-	-		SQNDT	SIGNAL SIGNAL
19	A	-	-	-	-		AG	SIGNAL SIGNAL	A->T:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) dbSNP:rs3879065 [MIM:125700];A->V:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) dbSNP:rs3879065 [MIM:125700]
20	C	-	-	-	-		C	DISULFID PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515" DISULFID PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515"
21	Y	-	-	-	-		YF	PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515" PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515"	Y->H:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) dbSNP:rs1219648 [MIM:125700]
22	F	-	-	-	-		IFL	PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515" PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515"
23	Q	-	-	-	-		QRGST	PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515" PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515"
24	N	-	-	-	-		N	PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515" PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515"
25	C	-	-	-	-		C	DISULFID PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515" DISULFID PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515"
26	P	-	-	-	-		PL	PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515" PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515"	P->L:(14.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) dbSNP:rs1428863 [MIM:125700]
27	R	-	-	-	-		RKNIEL	PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515" PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515"
28	G	-	-	-	-		GD	SITE /note="Important for agonist activity on V1aR/AVPR1A" MOD_RES /note="Glycine amide" MUTAGEN /note="G->V: Gain of antagonist activity on V1aR/AVPR1A (and loss of agonist activity on this receptor). 42-fold decrease in affinity for V1aR/AVPR1A, 2000-fold decrease in affinity for V1bR/AVPR1B, 5-fold decrease in affinity for V2R/AVPR2 and no change in affinity for oxytocin receptor (OXTR)." PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515" SITE /note="Important for agonist activity on V1aR/AVPR1A" MOD_RES /note="Glycine amide" MUTAGEN /note="G->V: Gain of antagonist activity on V1aR/AVPR1A (and loss of agonist activity on this receptor). 42-fold decrease in affinity for V1aR/AVPR1A, 2000-fold decrease in affinity for V1bR/AVPR1B, 5-fold decrease in affinity for V2R/AVPR2 and no change in affinity for oxytocin receptor (OXTR)." PEPTIDE /note="Arg-vasopressin" /id="PRO_0000020515"
29	G	-	-	-	-		G
30	K	-	-	-	-		KE
31	R	-	-	-	-		R
32	A		e	96.4	2bn2_A		ASDNEGKLTV
33	M		e	85.0	2bn2_A		VLIAYMFQTEGKS
34	S	S	e	41.4	2bn2_A		DPLHSQAMGIEFKNRTV
35	D	G	e	82.1	2bn2_A		DEMATS
36	L	G	e	92.1	2bn2_A	hetero NEU2_BOVIN	TLVIGRMAFPS
37	E	G	e	55.8	2bn2_A		DQEPGAYTSVK
38	L		e	30.9	2bn2_A	hetero metal CD	LVSPTGIQMA
39	R		e	32.4	2bn2_A	compound PHE homo	RTKHP
40	Q		e	35.2	2bn2_A		QKEPSAT
41	C		b	6.7	2bn2_A	hetero compound TYR	CADEGIKLNPQRSTV	DISULFID DISULFID
42	L		b	14.0	2bn2_A		MLAIVDEGKNPQRST
43	P	E	e	34.9	2bn2_A		PSFAKT
44	C	E	b	4.0	2bn2_A		C	DISULFID DISULFID
45	G	S	e	26.2	2bn2_A	hetero NEU2_BOVIN	GMSKAELTV		G->R:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
46	P	G	e	52.7	2bn2_A	hetero NEU2_BOVIN	PYLNAGSDEFIKQRTV
47	G	G	e	76.2	2bn2_A	hetero NEU2_BOVIN	GCRDEAIKLNPQSTV
48	G	G	e	46.4	2bn2_A		GDNSEALV		G->V:(1.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) dbSNP:rs1219648 [MIM:125700]
49	K		e	59.4	2bn2_A		KRFQVTA
50	G	E	b	3.6	2bn2_A		GALS
51	R	E	e	35.2	2bn2_A		RQHNLAGS		R->C:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
52	C	E	b	2.0	2bn2_A	hetero compound TYR	C	DISULFID DISULFID	C->R:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
53	F	E	b	9.6	2bn2_A	hetero compound TYR	FVLY
54	G	E	b	11.9	2bn2_A	hetero compound TYR	GA		G->R:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) dbSNP:rs1219648 [MIM:125700];G->V:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) dbSNP:rs1219648 [MIM:125700]
55	P	T	e	29.5	2bn2_A	hetero compound TYR homo	P		P->L:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
56	S	T	e	39.1	2bn2_A	homo	SNHRGQ
57	I	E	b	1.2	2bn2_A		IVT
58	C	E	b	0.0	2bn2_A		C	DISULFID DISULFID	C->F:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
59	C	E	b	0.7	2bn2_A		C	DISULFID DISULFID	C->R:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700];C->Y:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
60	A	E	b	7.1	2bn2_A		GA
61	D	T	e	74.1	2bn2_A		EDAGLQKPVS
62	E	T	e	76.9	2bn2_A		EGDALRPS
63	L	T	e	27.5	2bn2_A	hetero NEU2_BOVIN homo	LIFKMRTVADEGPS
64	G	E	e	29.8	2bn2_A	hetero NEU2_BOVIN homo	G
65	C	E	e	22.7	2bn2_A	hetero NEU2_BOVIN homo	CG	DISULFID DISULFID
66	F	E	e	20.1	2bn2_A	hetero NEU2_BOVIN homo	ELYFGWH
67	V	E	e	60.7	2bn2_A	hetero NEU2_BOVIN homo	MVILRF		V->A:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) dbSNP:rs2893487 [MIM:125700]
68	G	S	e	69.0	2bn2_A	hetero NEU2_BOVIN homo	G
69	T	S	e	33.8	2bn2_A	hetero NEU2_BOVIN homo	TSG
70	A	G	e	63.4	2bn2_A	hetero NEU2_BOVIN	APGTSVEL
71	E	G	e	39.2	2bn2_A	homo	ECDW
72	A	G	b	0.9	2bn2_A		ATIMS
73	L	G	e	64.6	2bn2_A	hetero NEU2_BOVIN	LANVEDRSMQ
74	R	G	e	42.7	2bn2_A	homo	RGVMSKTH
75	C	G	b	0.0	2bn2_A	hetero compound TYR	C	DISULFID DISULFID
76	Q	G	e	47.4	2bn2_A	hetero NEU2_BOVIN	QAVKMERHISFL
77	E	G	e	49.2	2bn2_A	hetero NEU2_BOVIN homo	ERKQG
78	E	G	b	9.0	2bn2_A	hetero compound PHE TYR	E		E->G:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
79	N	G	e	64.8	2bn2_A	hetero compound TYR PHE	NDESTI
80	Y	G	e	83.5	2bn2_A	hetero NEU2_BOVIN homo	YEFLDH
81	L		e	41.6	2bn2_A	hetero NEU2_BOVIN compound PHE homo	LDSHNM		L->P:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
82	P	S	e	103.1	2bn2_A	hetero NEU2_BOVIN compound PHE homo	PSLT		P->L:(5.0 %):LB/B - dbSNP:rs5195
83	S	S	e	43.0	2bn2_A	hetero compound PHE homo	STIEVA
84	P		e	72.9	2bn2_A	hetero NEU2_BOVIN compound PHE	P
85	C		e	21.3	2bn2_A	hetero compound PHE TYR	C	DISULFID DISULFID
86	Q		e	29.6	2bn2_A	hetero	QEHRAKL
87	S		b	0.8	2bn2_A		VSAGTIP		S->F:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) dbSNP:rs1219648 [MIM:125700]
88	G		e	20.2	2bn2_A		GFSLAKV		G->R:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700];G->S:(6.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) dbSNP:rs1219648 [MIM:125700]
89	Q	S	e	93.4	2bn2_A		GQR
90	K	S	e	48.1	2bn2_A		KRQSDEW
91	A	E	e	55.8	2bn2_A		PHRASVLDM
92	C	E	b	6.7	2bn2_A		C	DISULFID DISULFID	C->S:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700];C->Y:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) dbSNP:rs1219648 [MIM:125700]
93	G	T	e	63.1	2bn2_A		GNAS		G->W:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) dbSNP:rs1219648 [MIM:125700]
94	S	T	e	90.6	2bn2_A		SLNVDTAIY
95	G	T	e	79.8	2bn2_A	hetero	GENHATD
96	G	E	b	3.6	2bn2_A		GTA		G->C:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700];G->V:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) dbSNP:rs1219648 [MIM:125700];G->D:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
97	R	E	e	31.2	2bn2_A		RNIHSKPL		R->C:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700];R->P:(4.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
98	C	E	b	13.3	2bn2_A		C	DISULFID DISULFID	C->G:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700];C->S:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
99	A	E	b	2.7	2bn2_A		AV		A->P:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
100	A	E	b	2.7	2bn2_A		ASGTVR
101	F	T	e	66.1	2bn2_A		PDASINYFLTV
102	G	T	e	27.4	2bn2_A		G
103	V	E	e	25.1	2bn2_A	hetero NEU2_BOVIN homo	IVL
104	C	E	b	5.3	2bn2_A		C	DISULFID DISULFID	C->F:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700];C->G:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
105	C	E	b	0.0	2bn2_A		C	DISULFID DISULFID	C->R:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700];C->Y:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
106	N		b	17.6	2bn2_A		SDVNTGY
107	D	S	e	58.6	2bn2_A	hetero metal CD homo	DSAEHPTNV
108	E	S	e	81.4	2bn2_A	hetero NEU2_BOVIN metal CD homo	EDVQ
109	S		e	37.5	2bn2_A	hetero NEU2_BOVIN homo	TSGA
110	C	E	e	29.3	2bn2_A	hetero NEU2_BOVIN homo	C	DISULFID DISULFID
111	V	E	e	59.3	2bn2_A	hetero NEU2_BOVIN homo	SVTAKLHMR
112	T	E	e	77.3	2bn2_A	hetero NEU2_BOVIN homo	VIMATLF
113	E		e	24.1	2bn2_A		DHENS
114	P	T	e	88.4	2bn2_A		PSAQRLDTV
115	E	T	e	63.8	2bn2_A		SEARDGTLNV
116	C		e	22.7	2bn2_A		C	DISULFID DISULFID	C->G:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) dbSNP:rs7431538 [MIM:125700];C->R:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700];C->W:(0.0 %):LP/P Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]
117	R		e	83.0	1jk6_B		RLDEQSVHT
118	E	-	-	-	-		EDKVQSN
119	G	-	-	-	-		EGDAFIKLNPQRSTVY		G->V:(1.0 %):LB/B - dbSNP:rs1051744
120	F	-	-	-	-		FGVDSTEAL
121	H	-	-	-	-		DTSKPFHERGLAIV
122	R	-	-	-	-		ERQNAYDGIKLPSTV
123	R	-	-	-	-		RQEKDLSHP
124	A	-	-	-	-		ASDGTVILPQRY	DISORDER predicted by DISOPRED
125	R	-	-	-	-		REGSPI	DISORDER predicted by DISOPRED
126	A	-	-	-	-		VSAELPQ	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
127	S	-	-	-	-		STEDAGRFQP	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
128	D	-	-	-	-		DAEFQPSH	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
129	R	-	-	-	-		SREGPQVDY	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
130	S	-	-	-	-		SQAGKE	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
131	N	-	-	-	-		NDAESGKLTV	CARBOHYD /note="N-linked (GlcNAc...) asparagine" PEPTIDE /note="Copeptin" /id="PRO_0000020517" CARBOHYD /note="N-linked (GlcNAc...) asparagine" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
132	A	-	-	-	-		ALSTMQPVDEFGIKNR	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
133	T	-	-	-	-		TGLSANHDEKPV	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
134	Q	-	-	-	-		GQTLVDRSAEKP	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
135	L	-	-	-	-		LMAHDEFGIKNPQRSTV	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
136	D	-	-	-	-		DAGKENILPRSTV	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
137	G	-	-	-	-		GANSTLDEFIKPQRVY	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
138	P	-	-	-	-		PSLVADEFGIKNQRTY	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
139	A	-	-	-	-		ASPTDEFGIKLNQRVY	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
140	G	-	-	-	-		GSRTADEIKLNPV	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
141	A	-	-	-	-		DEAGIKLNPRSTV	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
142	L	-	-	-	-		LVIF	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
143	L	-	-	-	-		LI	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
144	L	-	-	-	-		LRMQ	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
145	R	-	-	-	-		RKWI	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
146	L	-	-	-	-		LVM	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
147	V	-	-	-	-		LMV	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
148	Q	-	-	-	-		HQLNR	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
149	L	-	-	-	-		LMF	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
150	A	-	-	-	-		AIS	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
151	G	-	-	-	-		GNSDA	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
152	A	-	-	-	-		AHTLR	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
153	P	-	-	-	-		TPQR	PEPTIDE /note="Copeptin" /id="PRO_0000020517" PEPTIDE /note="Copeptin" /id="PRO_0000020517"
154	E	-	-	-	-		EPQS	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
155	P	-	-	-	-		PSG	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
156	F	-	-	-	-		HVARFGLS	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
157	E	-	-	-	-		QEDR	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
158	P	-	-	-	-		PVS	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
159	A	-	-	-	-		AH	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
160	Q	-	-	-	-		QKA	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
161	P	-	-	-	-		P	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
162	D	-	-	-	-		GRD	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
163	A	-	-	-	-		VGA	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"
164	Y	-	-	-	-		Y	PEPTIDE /note="Copeptin" /id="PRO_0000020517" DISORDER predicted by DISOPRED PEPTIDE /note="Copeptin" /id="PRO_0000020517"